As noted above, the deletion of the rs55958994-associated enhancer leads to the down-regulation of ITGA5, CDH23, and CNTN1, to defects of tumor initiation, growth, and invasive migration, and to a decrease in the percentage of CSCs. The gene discussed is ITGA5; the disease is neoplasm.